Fundz

Cantai Therapeutics reported raising $3 Million in an initial SEC Form D filing, from an offering of $3 Million

PRIVATEJan 21, 2026

Amount Raised

$3 Million

$3 Million sold, per SEC Form D (first sale Jan 15, 2026)

Round Type

Seed

PhiladelpiaBiotechnology

Quick answer

Cantai Therapeutics raised $3 Million in a Seed round, dated January 15, 2026. Cantai Therapeutics is based in Philadelpia, Pennsylvania, United States.

How much did Cantai Therapeutics raise?
Cantai Therapeutics raised $3 Million in a Seed round on January 15, 2026.
What does Cantai Therapeutics do?
Cantai builds high-value, rationally designed bispecific antibodies that combine clinically validated mechanisms to achieve superior outcomes for patients with autoimmune disease.
Where is Cantai Therapeutics based and how big is it?
Cantai Therapeutics is based in Philadelpia, Pennsylvania, United States. Fundz records about 5 employees.
Who are the decision-makers at Cantai Therapeutics?
Fundz holds 2 contacts at Cantai Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Cantai Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Biohaven raised $600M (Debt Financing) on March 1, 2026.
  • Starling Medical raised $825K (Seed) on February 27, 2026.
  • Palvella Therapeutics raised $200M (Post-IPO Equity) on February 26, 2026.
  • Blue Arbor Technologies raised $5M (Series A) on February 26, 2026.
  • Salma Health raised $80M (Series A) on February 26, 2026.
  • Wholeleaf raised $165K (Seed) on February 26, 2026.

Who to call at Cantai Therapeutics, and when

A new round usually means Cantai Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Cantai Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cantai Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cantai Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cantai Therapeutics

Location

3675 Market Street, Suite 200

Philadelpia, Pennsylvania, United States

About

Cantai builds high-value, rationally designed bispecific antibodies that combine clinically validated mechanisms to achieve superior outcomes for patients with autoimmune disease.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cantai Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Cantai Therapeutics's next move

See what Strategic adds

Cantai Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.